Company / Operating Income
Immunocore Holdings plc Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$45.4M
FY2025
5-year range
-$174.6M / -$45.4M
FY2021-FY2025
Trend
+35.6%
vs FY2024
Sector context
#71 of 204
Health Care
What the data says
At -$45M, Immunocore Holdings plc's operating income ranks #71 of 204 in the Health Care sector. Operating Income returned to growth in FY2025 after 2 years of decline, reaching -$45M.
Based on SEC 10-K filings.
-$45M in FY2025.
Improved from -$60M to -$45M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#71 of 204 in Health CareTop 35% of 204This company -$45.4M Sector average $107.7M
▼
-142.1% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 35.6% year-over-year.
- Ranks #71 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$45.4M | +35.6% |
| FY2024 | -$70.5M | -18.1% |
| FY2023 | -$59.6M | -15.4% |
| FY2022 | -$51.7M | +70.4% |
| FY2021 | -$174.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026